Skip to content

EFFECT OF MAKARADHWAJA ON DIABETESE (MADHUMEHA)

A STUDY ON TWO SAMPLES OF SHADGUNA MAKARADHWAJA AND THEIR COMPARATIVE EFFECTS ON TYPE-II DM (MADHUMEHA)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/12/004200
Enrollment
50
Registered
2013-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Group A treated with Makaradhwaja prepared by Swarna Varkha : dose 14.63 mg along with Guduchi Ghana 235.37 mg orally twice a day Anupan Madhu. Duration:4 weeks Control Intervention1:

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients having classical symptomatology of Madhumeha (Type II D.M.) •Symptoms of Diabetes (Polyuria, Polydypsia, Polyphagia and Weight loss.) •Fasting plasma glucose >= 126 mg/dl and Post prandial glucose level >= 200 mg/dl.

Exclusion criteria

Exclusion criteria: •Patients of Diabetes Mellitus receiving Insulin. •Patients having chronic complications of Diabetes Mellitus 1.Microvascular: Retinopathy, Neuropathy, & Nephropathy. 2.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease. 3.Other chronic debilitating diseases like STD,TB,Leprosy .

Design outcomes

Primary

MeasureTime frame
â?¢Blood sugar level will be monitered with glucometer every week. â?¢Improvement in the signs and symptoms of the disease as per Ayurvedic texts. â?¢Investigations conducted before and after the treatment. Timepoint: 4 weeks

Secondary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of diseaseProgress in the signs and symptoms based on the standard pattern will be applied before and after treatment.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactProf PK Prajapati

IPGT AND RA

prajapati.pradeep1@gmail.com9428315733

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026